Novartis AG (NYSE:NVS) is a Swiss pharma giant known for drugs like Scemblix and Kisqali. It ranks 4th among cheap pharmaceutical stocks. Its success hinges on innovative drugs and strategic marketing to maintain revenue post-patent expiration.